Roche Pharmaceutical Development and Sales Overview

YTD Sep 2022: Group sales growth driven by Diagnostics Division 2022 2021 Change in % CHFbn CHFbn CHF CER Pharmaceuticals Division 33.2 33.4 -1 0 Diagnostics Division 13.8 13.3 4 6 Roche Group 47.0 46.7 1 2 CER=Constant Exchange Rates; totals may include differences due to rounding Roche 7

View entire presentation